Rapid-Medical , Ltd.
Rapid Medical is a global leader in neurovascular therapy, developing innovative, responsive, and remotely adjustable interventional tools to treat ischemic and hemorrhagic stroke. The company is committed to expanding what’s possible in neurovascular treatment through proprietary manufacturing techniques and a passionate, inclusive culture. With a focus on advancing stroke intervention, Rapid Medical aims to improve patient outcomes worldwide.
Industries
Nr. of Employees
medium (51-250)
Rapid-Medical , Ltd.
P.O.B. 337, Carmel building, Yokneam 2069205, Israel
Patents
Products
Adjustable mechanical thrombectomy device
A mechanically adjustable endovascular device intended to retrieve thrombus in ischemic stroke, enabling intra-procedural adaptation to vessel anatomy.
Steerable neurovascular guidewire
A steerable intracranial guidewire designed to improve access and navigation in neurovascular procedures.
Embolization assist device for aneurysm treatment
A temporary embolization assist device intended to support aneurysm coil embolization and remodeling procedures.
Robotic-assisted thrombectomy system
A robotic system designed to assist or perform aspects of endovascular thrombectomy procedures for ischemic stroke.
Active access / steerable access solution
An active access device intended to improve endovascular entry and navigation to distal cerebral vasculature.
Adjustable mechanical thrombectomy device
A mechanically adjustable endovascular device intended to retrieve thrombus in ischemic stroke, enabling intra-procedural adaptation to vessel anatomy.
Steerable neurovascular guidewire
A steerable intracranial guidewire designed to improve access and navigation in neurovascular procedures.
Embolization assist device for aneurysm treatment
A temporary embolization assist device intended to support aneurysm coil embolization and remodeling procedures.
Robotic-assisted thrombectomy system
A robotic system designed to assist or perform aspects of endovascular thrombectomy procedures for ischemic stroke.
Active access / steerable access solution
An active access device intended to improve endovascular entry and navigation to distal cerebral vasculature.
Services
In-person and virtual clinician training, user meetings and procedural workshops to support safe and effective use of neurovascular devices.
Regional sales, order management and local customer support through multiple global offices and distribution partners.
In-person and virtual clinician training, user meetings and procedural workshops to support safe and effective use of neurovascular devices.
Regional sales, order management and local customer support through multiple global offices and distribution partners.
Expertise Areas
- Neurovascular device development
- Clinical trial management for medical devices
- Regulatory compliance and submissions (FDA, CE, other national regulators)
- Robotic-assisted endovascular interventions
Key Technologies
- Adjustable mechanical thrombectomy mechanisms
- Steerable neurovascular guidewire mechanisms
- Robotic-assisted endovascular systems
- Embolization assist device design
News & Updates
Following FDA approval, Rapid Medical has begun initial neurovascular procedures in the US.
Rapid Medical has completed successful procedures using its innovative robotic thrombectomy device.
Rapid Medical announced Japanese approval and an exclusive partnership with Kaneka for its TIGERTRIEVER device.
The TIGERTRIEVER device has demonstrated high success rates in complex stroke cases.
The company received FDA approval for its innovative thrombectomy device.
The Tigertriever device has gained regulatory approval in China for stroke treatment.
Following FDA approval, Rapid Medical has begun initial neurovascular procedures in the US.
Rapid Medical has completed successful procedures using its innovative robotic thrombectomy device.
Rapid Medical announced Japanese approval and an exclusive partnership with Kaneka for its TIGERTRIEVER device.
The TIGERTRIEVER device has demonstrated high success rates in complex stroke cases.
The company received FDA approval for its innovative thrombectomy device.
The Tigertriever device has gained regulatory approval in China for stroke treatment.